No annual revenue total was found in Alamar Biosciences, Inc.'s SEC filings.
Alamar Biosciences, Inc. (ALMR) files with the SEC under industry code 3826, Laboratory Analytical Instruments. As of Sep 30, 2026 it held $226.6 million in cash and investments and $42.4 million in total debt.
Revenue
—
Net income
—
Operating cash flow
—
Free cash flow
—
EPS
—
Dividend per share
None
Shares outstanding
—
Net cash
$184.24M
as of Sep 30, 2026
Operating margin
—
Company profile
- Industry
- Laboratory Analytical Instruments (SIC 3826)
- Listed as
- ALMR (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Fremont, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 2104204
Other Laboratory Analytical Instruments companies
- Agilent Technologies, Inc. A
- Waters Corp /DE/ WAT
- Illumina, Inc. ILMN
- Mettler Toledo International INC/ MTD
- Revvity, Inc. RVTY
- Avantor, Inc. AVTR
- Bio-Rad Laboratories, Inc. BIO
- Bruker Corp BRKR
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Nov 3, 2026 | Oct 30, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 1, 2026 | Aug 28, 2026 |
| 10-Q | Quarterly report | Aug 11, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2026 | Aug 10, 2026 |
| 8-K |
Current report
Other events
|
Jul 15, 2026 | Jul 15, 2026 |
All 62 Alamar Biosciences, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.